
Lucia Health Guidelines develops an AI-powered mobile application and cloud-based platform to assist clinicians in diagnosing and managing Atrial Fibrillation (AFib) at the point-of-care, particularly in emergency rooms. Their solution uses proprietary machine learning algorithms trained by cardiac electrophysiology experts to provide timely, actionable EKG readings and guideline-based treatment plans aligned with national standards or hospital protocols. The platform also includes a transitions of care portal to ensure safe patient handoff to long-term care providers, improving patient outcomes, quality measures, and care coordination. The company aims to reduce strokes and healthcare costs by advancing guideline-based AFib treatment and stroke prevention, supported by clinical studies and strategic collaborations with organizations like the Heart Rhythm Society.

Lucia Health Guidelines develops an AI-powered mobile application and cloud-based platform to assist clinicians in diagnosing and managing Atrial Fibrillation (AFib) at the point-of-care, particularly in emergency rooms. Their solution uses proprietary machine learning algorithms trained by cardiac electrophysiology experts to provide timely, actionable EKG readings and guideline-based treatment plans aligned with national standards or hospital protocols. The platform also includes a transitions of care portal to ensure safe patient handoff to long-term care providers, improving patient outcomes, quality measures, and care coordination. The company aims to reduce strokes and healthcare costs by advancing guideline-based AFib treatment and stroke prevention, supported by clinical studies and strategic collaborations with organizations like the Heart Rhythm Society.
Product: AI-powered mobile app and cloud portal for AFib detection, guideline-based treatment recommendations, and transitions-of-care
Clinical evidence: Published AIM-HIGHER retrospective study in JACEP Open (2021); ER2EP pilot recognized at HRX 2023
Founders: Mathew Rothway (CEO & Co-Founder) and GilAnthony Ungab, MD (CMO & Co-Founder)
Funding signal: Received a grant recorded Aug 31, 2021 (Johnson & Johnson)
Clinical decision support for atrial fibrillation detection and guideline-based treatment at point-of-care, especially in emergency departments.
Health / Medical technology
Recorded as a grant on Aug 31, 2021; amount obfuscated in the source record
“Participated in an accelerator sponsored by Johnson & Johnson Impact Ventures and Village Capital”